Virus Nucleocapsid Assembly
Virus Nucleocapsid Assembly - Related Videos
09:08
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
0 Views •
2021
For in-depth mechanistic analysis of the respiratory syncytial virus (RSV) RNA synthesis, we report a protocol of utilizing the chaperone phosphoprotein (P) for coexpression of the RNA-free nucleoprotein (N0) for subsequent in vitro assembly of the virus-specific nucleocapsids (NCs).
02:36
In Vitro Reconstitution and Purification of Viral Nucleocapsid-Like Particles
0 Views •
2026
Source: Gao, Y., et al. Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus. J. Vis. Exp. (2021)The video demonstrates the in vitro assembly of virus-specific nucleocapsids from a purified RNA-free nucleoprotein–phosphoprotein complex, their purification by size exclusion chromatography, and validation of full-length viral RNA within the assembled particles.
12:45
Preparation of Viral DNA from Nucleocapsids
0 Views •
Cited by 40 •
2011
We describe the process of isolating high purity herpesvirus nucleocapsid DNA from infected cells. The final DNA captured from solution is of high concentration and purity, making it ideally suited for high-throughput sequencing, high fidelity PCR reactions, and transfections to produce new viral recombinants.
09:47
Simple and Robust in vivo and in vitro Approach for Studying Virus Assembly
0 Views •
Cited by 6 •
2012
A simple, efficient and robust way to synchronize the delivery of multiple viral components to plant cells via Agrobacterium-mediated transient expression is described. This approach is amenable for studying replication, encapsidation followed by in vitro reassembly of non-viral components into genome depleted optical viral ghosts suitable for biomedical applications.
08:33
Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
0 Views •
Cited by 8 •
2015
This protocol describes NAME, an assay that allows the rapid identification of molecules able to inhibit in vitro the chaperone activities of HIV-1 nucleocapsid protein.
FAQs
Sequential binding allows nucleoproteins to associate with the viral genome in an organized progression rather than through a single event. Those interactions can trigger conformational changes in the participating molecules, helping guide the formation of ordered particles. This coordination links molecular recognition with larger-scale assembly and influences how effectively the genome becomes organized for stability and transmission.
Protein–nucleic acid interactions provide the molecular specificity that determines how viral genetic material associates with nucleoproteins. Their organization helps distinguish controlled assembly from nonspecific aggregation and supports the ordered arrangement required for a functional particle. In biochemical studies, examining these interactions can reveal how viral genomes are compacted and protected within the developing nucleocapsid.
Self-assembly enables nucleoprotein–genome complexes to develop into ordered particles through the properties of their molecular interactions. The process does not merely bind components; it organizes them into a structure that can coordinate with other viral components during replication and packaging. This makes self-assembly an important principle for understanding viral particle formation and molecular organization.
Simple genome binding describes association between nucleoproteins and nucleic acid, whereas assembly includes the subsequent organization of those components into ordered particles. Sequential interactions, conformational changes, and self-assembly give the process a structural outcome beyond initial binding. This distinction matters because a stable, organized nucleocapsid must support genome stability and coordinate with other viral components.
Structural analyses can clarify how nucleoproteins and viral genomes are arranged within ordered particles, while biochemical analyses can examine the interactions and assembly behavior underlying that organization. Together, these approaches help connect molecular interactions with particle formation. Their findings can identify important interfaces and clarify how viral genetic material is organized during replication and packaging.
In biochemistry, this process provides a model for studying molecular self-organization and the control of genetic material by protein interactions. Research can also identify vulnerable interfaces involved in assembly, creating potential targets for antiviral development. The resulting structural and biochemical knowledge may further support vaccine and diagnostic design by clarifying how viral particles are organized.